By Dan Mitchell, MLM Blog Correspondent
From HighBeam Research:
SYDNEY, June 17 Asia Pulse – Biotech firm VRI BioMedical Ltd (ASX:VRI) has taken an order for its first product as part of a global supply agreement with United States-based Pharmanex.
VRI said the initial Pharmanex order for PCC, the company's exclusive probiotic isolates, would generate revenues of $A750,000 ($US417,375).
The order is part of a substantial global supply agreement that VRI has negotiated with Utah-based Pharmanex, it said.
The company said PCC was being contract manufactured in the USA and supplied by VRI as finished product in capsules.
Read more…
If you enjoyed this mlm blog post, then make sure you subscribe to the MLM Blog RSS Feed for all your MLM News.
